Nanomedicine News

RSS

Nanotechnology Researchers Elected to World's Largest Scientific Body

Five Brown University faculty have been awarded the distinction of fellow from the American Association for the Advancement of Science (AAAS). The new fellows, among 486 chosen from the AAAS membership this year, include...

18 Dec 2008

New Label-Free Imaging Technique Set to Revolutionize Biomedical Imaging

New Label-Free Imaging Technique Set to Revolutionize Biomedical Imaging

The key to this new chemical imaging technique is the use of two lasers with different frequencies. Researchers visualize samples by tuning the laser frequencies to match the vibrational frequency of a specific chemical bond. Each type of molecule within a sample, including nutrients or drugs, is detectable at a unique frequency.

18 Dec 2008

Coca Cola CEO Donates $6 Million Towards Cancer Nanotechnology Research

Coca-Cola Enterprises Inc. Chairman and CEO John Brock and his family have given $6 million to create two endowed faculty chairs at Emory University and Georgia Tech to support research in cancer nanotechnology. Brock...

18 Dec 2008

Multimillion Dollar Donation for Establishment of Pharmaceutical Nanotechnology and Nanotoxicology

Prof. Moein Moghimi (Professor of Biopharmacy and Nanomedicine, Department of Pharmaceutics and Analytical chemistry) and colleagues have received 28 million DKK (approximately 3.75 million Euros) from the Danish Council...

18 Dec 2008

Nanoparticle Targets Melanoma With siRNA

Specially designed small RNA molecules have proven very effective in decreasing the expression of specific genes that cancer cells need to survive; however, getting these RNA molecules inside cancer cells in living anima...

18 Dec 2008

Epeius Biotechnologies Files Patent for Leading Tumor-Targeted Gene Delivery Systems

Epeius Biotechnologies Corporation, a leader in tumor-targeted gene delivery systems, has received two additional European patents for the platform targeting technologies and molecular designs that enable precision gene ...

18 Dec 2008

Starpharrma Report Advancement in its Dendrimer-based Drug-Delivery Program

Starpharrma Report Advancement in its Dendrimer-based Drug-Delivery Program

A Starpharma dendrimer combined with a widely-used cancer drug (doxorubicin) has achieved a significant extension of the drug's plasma half-life and a marked reduction in drug toxicity compared to administration of the drug alone.

17 Dec 2008

New Nanochemistry Laboratory to Serve Worldwide Research Group with Custom-Made Nanomaterials

The new Nanochemistry Laboratory is located at the Institut de Science et d’Ingenierie Supramoleculaires (ISIS) of the University of Strasbourg, France and will be headed by Dr. Nina Matoussevitch, an experienced N...

17 Dec 2008

Examining the Ethical Issues on the Future of Synthetic Biology

Synthetic biology takes genetic engineering techniques developed in the 1970s many steps forward. Those methods were largely confined to moving genes from one organism to another. Now, using techniques from molecular bio...

17 Dec 2008

Researchers Identified Cancer Cells Defensive Mechanism

A team of researchers headed by Professor Roland Stauber of Mainz University's ENT clinic has identified a molecular mechanism used by cancer cells to "defend" themselves against chemotherapeutics in an att...

17 Dec 2008

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.